Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 13 analysts

Fate Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -61.8%, and profit growth estimate of 10.1% for FY25, based on top 13 analyst calls.